Healthcare


 How FDA approvals can change the fate of ASX-listed healthcare stocks

How FDA approvals can change the fate of ASX-listed healthcare stocks

February 19, 2020 06:54 PM AEDT| By Team Kalkine Media

The lucrative Australian healthcare sector often grabs investors’ attention with the potential to deliver remarkable profits. To understand the nitty-gritty of investing in healthcare stocks, a multifaceted approach is required. Multi...

 Medical Import landscape for AU and Stocks under discussion

Medical Import landscape for AU and Stocks under discussion

February 19, 2020 03:21 PM AEDT| By Team Kalkine Media

Medical and pharmaceutical imports are on the list of top ten imports of Australia. Pharmaceuticals account for approximately 3.6 per cent of Australian imports. Import of medical devices and medicines is regulated by the Department of Health and Aus...

 Mapping Prescient’s PTX-200 Progress

Mapping Prescient’s PTX-200 Progress

February 19, 2020 02:14 PM AEDT| By Team Kalkine Media

Known for developing breakthrough personalised medicines using an approach to address specific mutations that drive cancer, thereby providing resistance to front line chemotherapy,  Prescient Therapeutics Limited (ASX: PTX) has been gaining...

 Are these the top 5 Exciting Opportunities in Healthcare Space

Are these the top 5 Exciting Opportunities in Healthcare Space

February 19, 2020 12:39 AM AEDT| By Team Kalkine Media

In the health care sector innovation is required to find out the solutions for rare diseases and unmet medical needs. Many health care companies in Australia are investing an enormous amount of money in their R&D and developing new treatments and...

 Health Care Industry and Updates from Junior Players with high growth Prospects

Health Care Industry and Updates from Junior Players with high growth Prospects

February 18, 2020 07:31 PM AEDT| By Kunal Sawhney

Hon Greg Hunt MP, Minister for Health, Australia government stated that, “Good health is essential to our happiness and wellbeing. Australians overall are among the healthiest and longest living people in the world.” As per August 2019 r...

 Latest from the Healthcare Stocks- Starpharma and Pro Medicus

Latest from the Healthcare Stocks- Starpharma and Pro Medicus

February 18, 2020 03:10 AM AEDT| By Team Kalkine Media

Global Coronavirus outbreak, bushfire devastations, a turbulent political scene with uncertainty around one of the biggest elections in American history, 2020 is going to be a challenging year for the investors with approximately half of the American...

 Casting Eye on Winners of earnings season: Focus on Healthcare Stocks

Casting Eye on Winners of earnings season: Focus on Healthcare Stocks

February 17, 2020 11:02 PM AEDT| By Hina Chowdhary

Favourable corporate results were one of the main reasons the global markets, in general, have performed well despite the myriad challenges the world has had to face right from the trade war between the US and China to the emergence of the new corona...

 Is Coronavirus Gender Biased? Health Tips!

Is Coronavirus Gender Biased? Health Tips!

February 16, 2020 01:36 AM AEDT| By Team Kalkine Media

When it comes to mortality, surviving ailment or handling agony, women are found to be stronger than men. The slogan seems to be once again proved during the deadly epidemic of Coronavirus, as majority of the patients dealing with the virus are old...

 Healthcare outlook 2020; Will Polynovo Continue its Current Rally?

Healthcare outlook 2020; Will Polynovo Continue its Current Rally?

February 16, 2020 01:31 AM AEDT| By Hina Chowdhary

As global health is challenged by various demographic and economic changes, the advancements in the technology of all forms provide the opportunity to significantly alter the way healthcare services are delivered to meet a number of challenges. The...

 Biotechs on a rollercoaster; Western Australia looking to join the ride

Biotechs on a rollercoaster; Western Australia looking to join the ride

February 15, 2020 01:13 AM AEDT| By Hina Chowdhary

The demand on the healthcare sector has never been more apparent than right now as the world struggles to come up with a suitable treatment for COVID-19, that has killed more than 1300 people so far with a record rise in number of deaths in a single...

 How has Coronavirus impacted infant formula stocks?

How has Coronavirus impacted infant formula stocks?

February 13, 2020 07:36 PM AEDT| By Hina Chowdhary

Due to the outbreak of Coronavirus in China, there is an increased demand for essential items such as infant formula products. The alarming public health concerns have caused the foot traffic in mother and baby stores to increase substantially. Despi...

 Healthcare Stocks in Penny Space- IPD, ANP

Healthcare Stocks in Penny Space- IPD, ANP

February 13, 2020 05:32 PM AEDT| By Team Kalkine Media

 Healthcare is a lucrative and dynamic sector for investors, and amid ambiguity and fluctuating stock market environment, Australia’s healthcare system stands out as one of the top sectors for investment purpose. Investment in healthcare s...

 How coronavirus has impacted ASX stocks - Blackmores scraps dividend after profit tumbles

How coronavirus has impacted ASX stocks - Blackmores scraps dividend after profit tumbles

February 13, 2020 03:58 AM AEDT| By Kunal Sawhney

The death toll by coronavirus has increased to more than 1,000 and the World Health Organisation (WHO) has also proposed an official name for the illness caused by the new coronavirus as COVID-19. The acronym stands for coronavirus disease 2019. Aust...

 Healthcare stocks under check now post the Coronavirus outbreak- COH, CSL, HCT, ZNO

Healthcare stocks under check now post the Coronavirus outbreak- COH, CSL, HCT, ZNO

February 12, 2020 10:55 PM AEDT| By Kunal Sawhney

Latest data from global health authorities revealed that amid recent outbreak of the novel coronavirus (2019-nCoV) in China, more than 45,000 people globally have been infected with the death toll in mainland China soared past 1100, leaving healthcar...

 Healthcare Stocks in Discussion- The Latest with Starpharma and Alcidion Group

Healthcare Stocks in Discussion- The Latest with Starpharma and Alcidion Group

February 12, 2020 02:51 PM AEDT| By Team Kalkine Media

With the recent outbreak of the novel coronavirus (2019-nCoV) in Greater China, the healthcare space has gained massive traction alike from public authorities and private investors. Healthcare specialists have been exposed to a challenge to invent a...

 Biotron share price continues to rally on Coronavirus hopes

Biotron share price continues to rally on Coronavirus hopes

February 11, 2020 02:48 PM AEDT| By Team Kalkine Media

The stock price of Sydney based healthcare player, Biotron Limited (ASX:BIT) increased by approximately a quarter percent during the day’s trade on 10 February 2020. The stock settled at the price of $0.157, moving closer to its 52-weeks high p...

 Coronavirus Outbreak: Swings and Roundabouts

Coronavirus Outbreak: Swings and Roundabouts

February 10, 2020 09:22 PM AEDT| By Hina Chowdhary

With more than 37,000 confirmed cases of novel coronavirus (nCoV) and over 900 reported deaths across the world, coronavirus has undoubtedly become a head throbbing matter for the health ministries. The Australian government has so far validated 15 c...

 Coronavirus Continues to Threaten ASX Stocks; Impact on Kathmandu Holdings and Crown Resorts

Coronavirus Continues to Threaten ASX Stocks; Impact on Kathmandu Holdings and Crown Resorts

February 10, 2020 07:01 PM AEDT| By Team Kalkine Media

The Australian Government on 7 February 2020 has provided a summary which gives the latest update on novel coronavirus in Australia. As of morning, on that date, there were 15 cases of 2019-nCoV which has been confirmed in Australia. Out of these 15...

 US stocks reach new highs as China moves to limit Coronavirus impact

US stocks reach new highs as China moves to limit Coronavirus impact

February 10, 2020 04:31 PM AEDT| By Team Kalkine Media

If you are one of the equity investors irrespective of which part of globe you reside, it is highly likely that the news about the outbreak of coronavirus would have sent you palpitating to check the performance of the stock market. The onset of Wuha...

 Noxopharm Seeks to Bring Veyonda® to Market as a First-in-class Drug to Boost the Effectiveness of Radiation Therapy in Prostate Cancer

Noxopharm Seeks to Bring Veyonda® to Market as a First-in-class Drug to Boost the Effectiveness of Radiation Therapy in Prostate Cancer

February 10, 2020 02:58 PM AEDT| By Team Kalkine Media

Noxopharm Limited (ASX:NOX), an Australian clinical stage biotechnology company with its focus on oncology, is known for developing a novel, potentially transformative and industry disruptive cancer drug treatment using its lead candidate, Veyonda&re...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.